ACP member since 2005
Phillip O. Coffin, MD, is director of Substance Use Research at the San Francisco Department of Public Health and assistant clinical professor in the HIV/AIDS Division at the University of California San Francisco. He is a board-certified internist and infectious disease clinician with active practices, including HIV care, infectious disease consultation, and hospital medicine. His research interests focus on substance use, where he serves as principal investigator and director for clinical trials and evaluation research of pharmacologic and behavioral interventions addressing the use and medical sequelae of methamphetamine, opioids, and alcohol.
Dr. Coffin is being recognized for an article he authored within three years of completing his training. "Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal." His research showed that distributing naloxone to heroin users to use to reverse overdose is a cost-effective strategy to reduce overdose-related mortality.
The Annals' Junior Investigator Recognition Awards are presented annually to two early career physicians. Winners are selected based on the article's novelty, methodological rigor, clarity of presentation, and potential to influence practice, policy, or future research.